Showing results (2271-2280 of 2,887) with videos related to

Sort By:
Pageof 289
Thyroid : Official Journal of the American Thyroid Association|December 17, 2021
What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features' Nomenclature RevisionVikas Mehta, Ankita Naraparaju, David Liao, et al.
Oncotarget|June 17, 2015
Identification and characterization of RET fusions in advanced colorectal cancerAnne-France Le Rolle, Samuel J Klempner, Christopher R Garrett, et al.
Radiology|June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CTGary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
Cancer|October 7, 2005
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinomaLee M Krug, Vincent A Miller, Jyoti Patel, et al.
The Science of the Total Environment|September 1, 2018
Seasonal variability in vulnerability for Cassin's auklets (Ptychoramphus aleuticus) exposed to microplastic pollution in the Canadian Pacific regionPatrick D O'Hara, Stephanie Avery-Gomm, Jocelyn Wood, et al.
JMIR Research Protocols|May 25, 2017
The Use of Text Messaging to Improve the Hospital-to-Community Transition in Acute Coronary Syndrome Patients (Txt2Prevent): Intervention Development and Pilot Randomized Controlled Trial ProtocolEmily S Ross, Brodie M Sakakibara, Martha H Mackay, et al.
Seminars in Thoracic and Cardiovascular Surgery|September 16, 2004
10-year follow-up of patients with and without mediastinitisJohn H Braxton, Charles A S Marrin, Paul D McGrath, et al.
Spine|February 14, 2009
Anatomical and biomechanical analyses of the unique and consistent locations of sacral insufficiency fracturesNathan J Linstrom, Joseph E Heiserman, Keith E Kortman, et al.
Cancer Medicine|January 15, 2026
Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic ImplicationsDouglas I Lin, Elizabeth Lawrence, Natalie Danziger, et al.
Breast Cancer Research and Treatment|June 13, 2024
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practiceManali A Bhave, Julia C F Quintanilha, Hanna Tukachinsky, et al.
Pageof 289